Sundaram Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.15 M
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 Cr
- Revenue Growth 114.03%
- Profit Growth 243.70%
- Ebitda 162.09%
- Net Worth 78.12%
- Total Assets 109.26%
About Sundaram Pharma
Sundaram Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 November 2004 and has a history of 20 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹3.50 Cr.
Dinesh Singh, Brijesh Singh, and Dhroov Singh serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397MH2004PTC149475
-
Company No.
149475
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Nov 2004
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Sundaram Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Singh
|
Director | 01-May-2023 | Current |
|
Brijesh Singh
|
Director | 09-Nov-2004 | Current |
|
Dhroov Singh
|
Director | 15-Mar-2022 | Current |
Financial Performance of Sundaram Pharma.
Sundaram Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 114.03% increase. The company also saw a substantial improvement in profitability, with a 243.7% increase in profit. The company's net worth Soared by an impressive increase of 78.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sundaram Pharma?
Unlock access to Sundaram Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Prevego Healthcare & Research Private LimitedBrijesh Singh is a mutual person
-
Chandra-Corbox Packaging Private LimitedDinesh Singh and Brijesh Singh are mutual person
-
Satyam Generic Pharma Private Limited
Dinesh Singh, Brijesh Singh and 1 more are mutual person
-
Geminova Pharmaceuticals Private Limited
Brijesh Singh is a mutual person
Charges (Loans)
₹35.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 3.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Apr 2024 | Others | ₹3.50 Cr | Open |
How Many Employees Work at Sundaram Pharma?
Unlock and access historical data on people associated with Sundaram Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sundaram Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sundaram Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
